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Background: Evaluate the performance of the Focalpoint system in identifying and classifying cervical cytology
alterations from samples collected from patients treated with Radiotherapy (RT).
Methods: The reproducibility of manual and automated screening by cytotechnologists using the BD Focalpoint
GS Imaging System was examined. Samples were collected from May 2010 to August 2011.
Results: A total of 378 treated with RT and 8,967 cytology samples from patients without previous RT, were
evaluated. The kappa values for cytological diagnoses read manually and automated in cases without previous
RT were as follows: < ASC-H vs. ≥ ASC-H = 0.71; < LSIL vs. ≥ LSIL = 0.66; and < HSIL vs. ≥ HSIL = 0.67. The kappa for
cytological diagnoses in post-RT women have showed: < ASC-H vs. ≥ ASC-H = 0.71; < LSIL vs. ≥ LSIL = 0.65; < HSIL
vs. ≥ HSIL = 0.57.
Conclusions: There was no significant difference among the kappa values we found. Post-RT cytology showed
small diagnostic agreement between manual and automated examination.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/13000_2014_231
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Radiotherapy (RT) is commonly used to treat invasive
cervical cancer and other gynaecological malignancies
and has high treatment efficacy [1]. RT, however, can
induce important changes in cellular morphology that can
generate bizarre cell shapes that persist for several years
[2]. Despite some controversies, cervicovaginal cytology
remains an auxiliary tool for diagnosing gynaecological
tumour recurrence after radiotherapy [1]. Nevertheless,
most abnormalities related to radiation exposure should
be carefully evaluated to avoid misinterpretation [1]. Atyp-
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unless otherwise stated.mimicking Chlamydia infection, and koilocytosis-like
structures mimicking human papillomavirus (HPV)
infection are frequently observed after radiotherapy and
represent sources of cytological misdiagnosis [3-5].
The difficulties in interpreting post-RT cervical samples,
usually obtained from conventional Pap test smears, were
also observed in liquid-based cytology (LBC) preparations.
However, patients’ cells are generally well-preserved in
LBC samples. Wright and colleagues [5] reported an index
of satisfactory samples similar to that of non-irradiated
samples (approximately 97%), and associated benign alter-
ations after radiation were found in approximately 50% of
cases. Despite the well-known limitations of cytology in
precisely categorising cytological findings after RT, the
frequency of positive Pap tests for HSIL or squamous
cell carcinoma (SCC) after RT is generally low, which
minimises the potential errors [6].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a useful tool with which to safely accelerate an accurate
cytological screening. Although there is limited evidence,
the sensitivity of automated screening seems similar to
that of manual screening [7]. The available data, how-
ever, are conflicting. Nevertheless, to achieve acceptable
performance in relation to automated screening, manual
screening must be restricted to very low workloads (≤41
slides/day) [8]. The efficacy of the Pap test in revealing
cytological abnormalities largely depends on the time
spent on the screening in addition to the professional
skill of the cytotechnologists [8]. Regardless, automated
screening is an important option for an internal quality
control system, as the number of cytotechnologists has
recently been decreasing, and the HPV vaccine is likely
to reduce the accuracy of cytological examination due to
the associated decreasing number of cervical abnormalities
[9,10]. Consequently, automation seems to be a promising
tool to assure the quality of a cytology laboratory and avoid
errors. Moreover, positive effects of automation on prod-
uctivity have been reported [9]. All together, these findings
seem realistic for ordinary samples but not necessarily for
those from post-RT patients. Preneoplastic changes in
women undergoing radiotherapy due to genital cancers
were proven to be HPV-related lesions, demonstrating
that the candidate HPV assay is a powerful ancillary test
for cytology [11].
This study aimed to compare the cytological interpret-
ation of samples collected from women who did or did
not undergo previous pelvic RT analysed manually versus
samples analysed under Focalpoint (FPGS) guidance.
Methods
The cytological samples were prepared and examined at
the Barretos Cancer Hospital between May 2010 and
August 2011. A total of 9,345 cervicovaginal cytologies
preserved in SurePath™ solution were analysed. The
samples were prepared in the BD PrepStain™ System
(Burlington, NC, USA) according to the manufacturer’s
instructions.
The manual screening of the slides was routinely per-
formed using light optical microscopes by well-trained
cytotechnologists. These slides were re-analysed under
guidance of the Focalpoint system (Burlington, NC, USA)
and randomly and blindly re-evaluated after 12 months by
the same group of cytotechnologists using the automated
screening Guided Screening Review Station (GS) of the
BD Focalpoint GS Imaging System (FPGS). No additional
training was applied for the cytotechnologists between the
first and the second round of slides’ review.
Cytology classification followed the Bethesda system
[12]. Prevalence ratios were calculated and compared
based on their 95% confidence intervals. The kappa coef-
ficients and the respective 95% confidence intervals werecalculated to evaluate the diagnostic agreement among
the cytotechnologists for both manual and computer-
guided screenings.
We also evaluated the frequency and prevalence ratio
of cytological results and compare with biopsy CIN 2 +.
All women enrolled in this study signed informed con-
sent forms to participate in the study, which was approved
by the Ethics committee of the Barretos Cancer Hospital
(id number 244/2009).
Results
Of the 9,345 liquid-based Pap tests available for this
analysis, 378 were collected from women who had been
previously treated with RT. Tables 1 and 2 shows the
frequency and prevalence ratio of cytological results
according to RT status read manually and under FPGS
assistance, respectively. Cytological abnormalities were
more frequent in the RT arm for both screening tools:
manual and automated. In Table 1 the prevalence ratios
were significantly higher in the RT group for the following
diagnoses: ASC-H +AGC (5.0), LSIL (2.4), and HSIL or
worse (3.5) and in Table 2 ASC-H +AGC (4.0), LSIL (1.8),
and HSIL or worse (4.8).
Tables 3 and 4 compares the biopsy CIN2+ rates dis-
tributed according to RT status and cytology results read
manually and under FPGS assistance, respectively. No
significant difference was found in the CIN2+ proportion
between the groups with and without previous radiother-
apy for all cytological categories.
We also evaluated the diagnostic concordance among
cytotechnologists in manual and automated screening.
Table 5 shows the kappa coefficients according to RT
status. There was no difference in the kappa values
according to RT status and cytologic abnormality (< ASC-
H vs. ≥ ASC-H; < LSIL vs. ≥ LSIL; < HSIL vs. ≥ HSIL).
Figures 1 and 2 shows the morphological post-
radiotherapy effects on the cells preserved in liquid
medium.
Discussion
The results obtained in this study are unique and original
in Brazil. The results demonstrated that previous radio-
therapy could introduce important morphological changes
that inhibit the specific classification of cellular alterations
and favours the cytological categorisation of uncertainty.
In our laboratory, we introduced the concept of internal
quality control in cytology supported by an automated
method of analysis in order to improve cytological inter-
pretation, theoretically reducing the errors of cytological
classification. The subjectivity of manual screening per-
formed by cytotechnologists was examined critically and
accurately, and the results obtained in this study provide
interesting data to support a significant change in the
paradigm of cervical cancer prevention in our hospital,
Table 1 Number and percentage of cases according to
cytology result and previous radiotherapy status read
manually
Cytology
result
No previous
radiotherapy
Previous
radiotherapy
PR 95% CI
(PR)
N (%) N (%)
Negative 8,589 (95.8) 327 (86.5) 0.9 0.87 – 0.94
ASCUS 72 (0.8) 6 (1.6) 2.0 0.9 – 4.5
ASC-H + AGC 83 (0.9) 17 (4.5) 5.0 2.9 – 8.1
LSIL 107 (1.2) 11 (2.9) 2.4 1.3 – 4.5
HSIL or worse 116 (1.3) 17 (4.5) 3.5 2.1 – 5.7
PR = prevalence ratio (ratio of cytology abnormalities between the groups who
did or did not receive previous radiotherapy).
95% CI = 95% confidence interval.
Table 3 Number and percentage of CIN2+ cases based on
the biopsies according to cytology result and previous
radiotherapy status read manually
Cytology result No previous
radiotherapy
Previous
radiotherapy
PR 95% CI
(PR)
N (%) N (%)
ASCUS + ASCH + AGC 34 (40.5) 6 (33.3) 0.8 0.4 – 1.7
LSIL 20 (37.0) 1 (25.0) 0.7 0.1 – 3.8
HSIL or worse 77 (74.8) 9 (60.0) 0.8 0.5 – 1.2
PR = prevalence ratio (ratio of cytology abnormalities between the groups who
did or did not receive previous radiotherapy).
95% CI = 95% confidence interval.
Stein et al. Diagnostic Pathology  (2015) 10:1 Page 3 of 5whereby automation can serve concurrently as an option
for primary screening and/or as an important tool for
internal quality control of cytological diagnosis. Our find-
ings demonstrated, however, that automated screening
offers diagnostic performance similar to that of the man-
ual method, even in cases of high-grade lesions, when per-
formed by highly well-trained professionals. These results
enabled the automated system FPGS to be introduced into
the routine protocol of the cytology laboratory of the
Department of Pathology of Barretos Cancer Hospital.
The post-radiation cytology assessment performed in
the present study offered substantial data concerning
the quality and limitations of cytological examination
by automated equipment. The frequencies of lesions
found after radiotherapy were as follows: ASC (ASCUS,
ASC-H, and AGC), 6.1%; LSIL, 2.9%; and HSIL or worse,
4.5% read manually and read under FPGS orientation
were: ASC 8,2%, LSIL 2,9% and HSIL or worse 4,8%.
These results are different from those obtained by Wright
and colleagues [5], who reported lower frequencies of
HSIL or worse than our study (ASCUS, 5.1%; LSIL, 1.0%;
HSIL, 0.3%; and carcinoma, 0.7%). Our results are also
different from an Italian study, where frequencies ranged
from 9.2% for cancer to 13.8% for atypical squamous
cells of undetermined significance [13]. These large var-
iations among studies clearly emphasise the difficultiesTable 2 Number and percentage of cases according to
cytology result and previous radiotherapy status read
under FPGS orientation
Cytology
result
No previous
radiotherapy
Previous
radiotherapy
PR 95% CI
(PR)
N (%) N (%)
Negative 8,524 (95.1) 316 (83.6) 0.9 0.84 – 0.92
ASCUS 89 (1.0) 13 (3.4) 3.4 1.95 – 6.14
ASC-H + AGC 109 (1.2) 18 (4.8) 4.0 2.40 – 6.38
LSIL 146 (1.6) 11 (2.9) 1.8 0.98 – 3.27
HSIL or worse 99 (1.1) 20 (5.3) 4.8 3.00 – 7.66of categorising the effects induced in cervical cells by
radiation. The biopsy study of these alterations (Tables 3
and 4), however, reflects the under- and over-estimation
that these ionising effects induce, as most of the cyto-
logical results are not corroborated by histopathological
evaluation. In our study, numerous cases of post-radiation
high-grade lesions identified by cytology were not con-
firmed by biopsy. This finding illustrates that cytological
alterations did not correspond to tissue modifications
compatible with the diagnosis of intraepithelial lesions.
Accordingly, ancillary methods for diagnosis and monitor-
ing of post-radiotherapy patients are necessary to avoid
alarming patients and performing unnecessary invasive
biopsies.
It is also relevant to emphasise that the manual screen-
ing in this study occurred under routine conditions, but
for the automated screenings, which were executed almost
one year after the initial diagnoses, the cytotechnologists
read all the slides blinded of any clinical and laboratorial
information of patient (including RT status), which could
certainly have influenced the morphological classification.
This is especially true for dubious cytological alterations
that are frequently found in cases of cell atrophy alter-
ations and post-radiotherapy cytological preparations. For
this reason, the analyses of diagnostic reproducibility were
performed separately for patients who had and had not
undergone RT.
The agreement between the manual and automated
screening techniques demonstrated that there was sub-
stantial agreement among the cytotechnologists regardingTable 4 Number and percentage of CIN2+ cases based on
the biopsies according to cytology result and previous
radiotherapy status read under FPGS orientation
Cytology result No previous
radiotherapy
Previous
radiotherapy
PR 95% CI
(PR)
N (%) N (%)
ASCUS + ASCH + AGC 41 (32.5) 10 (50.0) 1.54 0.93 – 2.55
LSIL 20 (15.9) 2 (10.0) 0.63 0.16 – 2.49
HSIL or worse 65 (51.6) 8 (40.0) 0.78 0.44 – 1.36
Table 5 Kappa values between manual and automated screening among cytotechnologists in women who did or did
not undergo previous radiotherapy
Diagnoses
< ASC-H vs. ≥ ASC-H < LSIL vs. ≥ LSIL < HSIL vs. ≥ HSIL
Kappa 95% CI Kappa 95% CI Kappa 95% CI
No previous radiotherapy N = 8,967 0.71 (0.67-0.75) 0.66 (0.61-0.71) 0.67 (0.60-0.74)
Previous radiotherapy N = 378 0.71 (0.60-0.82) 0.65 (0.51-0.80) 0.57 (0.38-0.77)
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agreement varied significantly for patients who had
undergone RT, ranging from substantial agreement with
regard to ASC-H and LSIL classifications to moderate
agreement for HSIL categorisation. Not surprisingly, the
results showed similar kappa values among all observers
except for cases of high-grade lesions in patients who had
undergone RT, which yielded lower kappa values. Lower
concordance from patients’ samples after RT is expected
due to the bias that radiation induces, which favours the
cytological categorisation of uncertainty.
To the best of our knowledge, no study focusing on
FPGS use in post-radiotherapy cervical samples has been
reported. Few recent studies evaluating the reproducibility
of cytological screening using liquid-based preparations
have demonstrated interesting results with image digitalisa-
tion. Tsilalis and colleagues [14] studied the performance
of a group of pathologists who analysed digital cytology
images; this same group reassessed the same images after
12 and 24 months, and the agreement between the readings
varied from substantial to excellent, with kappa values
varying between 0.79 and 0.97. Through the quality pro-
gram in Austria, the Pap tests of patients with invasive
cervical carcinoma collected in the 5 years prior to disease
detection were re-evaluated. The kappa values found
between the original and re-assessed readings of the slides
were only moderate [15].Figure 1 Multinucleated, bizarre cell with nuclear dyskaryosis
resulting from radiation (X100, Papanicolaou stain).A moderate reproducibility has been the most common
finding in reports related to the interobserver interpreta-
tions of cervical cytological under different scenarios
[14]. Our study demonstrated interesting data regarding
the performance of cytotechnologists, as most of the
results showed substantial reproducibility. Additionally,
the significant reproducibility with different kappa values
between the two screening techniques shows that the
replacement of manual screening with automated screen-
ing does not cause loss of positive cases, with high levels
of agreement between the manual and automated
screening.
Liquid-based cytology has also additional value intro-
ducing the molecular biology approach among different
lesions from several regions with diverse types of cyto-
logical samples. Of note, the relevance of hTERC ampli-
fication are feasible to be analysed by FISH technique
associated with more progressive CIN3 and carcinoma if
present in HPV positive cases in cervical material [16].
Similarly, the genomic amplification pattern of human
telomerase RNA gene test was demonstrated to be highly
sensitive and suitable for cervical cancer screening in
samples preserved in liquid medium, but not C-MYC test
because of its lower sensitivity [17]. New options of cellu-
lar staining are currently available to improve the quality
of the traditional staining protocols observations [18]. InFigure 2 Post-irradiation isolated cells with an atrophic pattern
and slight morphological alterations (X40 magnification,
Papanicolaou stain).
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tools could be also used with the ancillary assistance of
computerized screening.
Conclusion
The potential use of automation in underserved regions is a
good option to compensate for the absence of well-trained
professionals for slide reading. Moreover, automated read-
ing can improve both the primary screening and/or internal
quality control of cytological diagnosis by selecting appro-
priate fields of observation for cytotechnologists in samples
with and without RT effects.
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